Anterix (NASDAQ:ATEX) CFO Elena Marquez Sells 4,981 Shares of Company Stock

Anterix Inc. (NASDAQ:ATEX) CFO Elena Marquez sold 4,981 shares of the business’s stock in a transaction on Friday, October 9th. The stock was sold at an average price of $80.43, for a total transaction of $400,621.83. Following the completion of the transaction, the chief financial officer owned 12,604 shares in the company, valued at $1,013,739.72. This represents a 28.33% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Anterix Price Performance

NASDAQ:ATEX opened at $84.87 on Wednesday. The firm has a 50-day moving average of $86.36 and a two-hundred day moving average of $75.38. Anterix Inc. has a 1-year low of $17.58 and a 1-year high of $113.00.

Anterix (NASDAQ:ATEX) last announced its earnings results on Tuesday, August 11th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.43) by $0.44. Anterix had a negative return on equity of 10.65% and a net margin of 933.03%. The business had revenue of $1.96 million for the quarter, compared to analyst estimates of $2.00 million. On average, research analysts expect that Anterix Inc. will post -2.00 EPS for the current year.

Wall Street Analysts Forecast Growth

ATEX has been the topic of a number of recent analyst reports. DA Davidson set a $161.00 target price on Anterix in a research report on Friday, August 21st. Clear Str raised shares of Anterix to a “strong-buy” rating in a research report on Monday, July 27th. Wall Street Zen downgraded shares of Anterix from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. JPMorgan Chase & Co. dropped their price target on shares of Anterix from $133.00 to $130.00 and set an “overweight” rating for the company in a research note on Thursday, August 13th. Finally, Weiss Ratings raised shares of Anterix from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, October 2nd. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $120.00.

Hedge Funds Weigh In On Anterix

Several large investors have recently modified their holdings of ATEX. Integrated Wealth Concepts LLC acquired a new position in shares of Anterix in the 2nd quarter worth approximately $35,000. Parallel Advisors LLC increased its holdings in shares of Anterix by 63.7% in the 1st quarter. Parallel Advisors LLC now owns 933 shares of the company’s stock valued at $36,000 after acquiring an additional 363 shares during the last quarter. Fifth Third Bancorp bought a new stake in shares of Anterix in the 1st quarter valued at approximately $64,000. Royal Bank of Canada raised its position in shares of Anterix by 151.2% during the 1st quarter. Royal Bank of Canada now owns 3,034 shares of the company’s stock valued at $116,000 after acquiring an additional 1,826 shares in the last quarter. Finally, Legal & General Group Plc acquired a new stake in shares of Anterix during the 2nd quarter valued at approximately $222,000. Institutional investors own 87.67% of the company’s stock.

Anterix Company Profile

Anterix Inc (NASDAQ: ATEX) develops and enables private wireless broadband networks for critical infrastructure organizations in the United States. The company focuses on using its licensed 900 MHz spectrum to support secure, reliable communications for electric utilities and other organizations that require resilient connectivity for operational technology and field personnel.

Anterix provides spectrum access and related solutions designed to help utilities modernize communications networks, including support for grid management, outage response, remote monitoring, automation and other mission-critical applications.